Navigation Links
Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds
Date:1/25/2008

DAVOS, Switzerland, Jan. 25 /PRNewswire/ -- 3.5 million lives could be saved over the next five years through the rapid scale-up of malaria prevention and treatment measures in the 30 hardest hit countries in Africa, according to a new report released today at the World Economic Forum. Additionally, rapid scale-up would increase annual economic output by as much as $30 billion in Africa, prevent 672 million malaria cases, and free up 427,000 needed hospital beds over five years.

"We Can't Afford to Wait: The Business Case for Rapid Scale-up of Malaria Control in Africa," was prepared by Malaria No More and McKinsey & Company on behalf of the Roll Back Malaria Partnership (RBM). Providing specific cost and impact data as part of a rigorous business analysis, the report makes a compelling humanitarian and economic case for expanded access to proven malaria-control tools such as long-lasting insecticide-treated mosquito nets, life-saving anti-malarial medicines, and targeted insecticide spraying.

Current spending on malaria control in Africa is roughly $1 billion a year. The Malaria No More/McKinsey & Company report estimates that prevention and treatment measures could be brought to scale in the 30 African countries that together account for roughly 90 percent of global malaria deaths for approximately $2.2 billion a year over five years. This is an achievable and justifiable investment that would produce vastly superior results than the current trajectory, the report concludes.

Field studies show that as coverage levels rise, infection rates drop off more quickly, creating a situation of increasing returns. In comparison to the current projected growth in coverage, a rapid scale-up effort would save an additional two and a half million lives, prevent an additional 430 million malaria cases, and generate $20 billion more in annual GDP after five years. Rapid scale-up would also be far more cost-effective, saving twice as many lives for ever
'/>"/>

SOURCE Malaria No More
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Weight Watchers to Present at Credit Suisse 10th Annual Global Services Conference
2. New CDC Global Survey Finds Tobacco Taking Massive Toll on Worlds Children
3. Global Sales Veteran Jack McGovern Joins MediKeeper
4. Fleishman-Hillard Names FFI Global Cause for 2008
5. Lighting up the powerful global smoking lobby
6. Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes
7. Global Environment partners provide additional $20 million to protect endangered habitats
8. Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine
9. NPR, Harris Corporation and Towson University Launch Global Effort To Make Radio Accessible to Hearing and Sight Impaired
10. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
11. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... CO (PRWEB) November 22, 2014 ... growth equity investments in the consumer brand sector, ... The investment will be used to help fund ... product pipeline rollout, particularly its proprietary apparel and ... will join BackJoy’s Board of Directors. , BackJoy ...
(Date:11/22/2014)... A Xarelto lawsuit has been filed on behalf of ... in damages from the makers and marketers of the ... woman began using Xarelto in March 2012 and used it ... suffered life-threatening bleeding in July 2012 and as a result, ... distress. The lawsuit purports that the woman’s injuries are due ...
(Date:11/22/2014)... Nov. 21, 2014 (HealthDay News) -- The widely used ... death and hospitalization among patients who have the heart ... failure, a new study finds. Atrial fibrillation is ... linked to a rise in risk for stroke among ... a century to help treat irregular heartbeat, the authors ...
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- Seeking to make ... U.S. Food and Drug Administration on Thursday approved a ... Hydrocodone -- best known by the brand name ... been tied to a surge in dangerous addictions across ... approved Hysingla ER (hydrocodone bitartrate) is an extended-release tablet ...
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... Probiotics for Pets helps maintain digestive health and can ... intestinal flora after it experiences a period of stress, ... for Pets is a proprietary blend of pure probiotics ... active bacteria strains that are safe and effective for ...
Breaking Medicine News(10 mins):Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 2Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 3Health News:Xarelto Lawsuit News: Woman Seeks $10 Million in Damages For Alleged Bleeding Side-Effect Due To Xarelto Use 4Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2
... , BIRMINGHAM, Ala., Aug. 19 ... more individuals, organizations, and society will continue to ... and communication technology or (ICT). With an ever-expanding ... GASICORP, worldwide leader in information and communication technology, ...
... CHICAGO, Aug. 19 As Electronic Health Record (EHR) Solution Providers race ... e ntric, Inc , offers practical advice for evaluating and designing ... We b i nars will highlight techniques used ... clinician performance while increasing adoption. , , Measuring and improving ...
... NEW YORK, Aug. 19 Bayard Advertising Agency, Inc., ... clients in a broad array of industries, announces its selection ... (HCA) West Florida Division. , , ... notes Jennifer Berres, VP Human Resources for HCA West Florida ...
... ... have a healthier lifestyle by health experts from Avon Obesity Service. , ... (PRWEB) August 19, 2009 -- A smoking alternative has been suggested ... ,Patients have been introduced to the Intellicig electronic cigarettes at Avon Obesity ...
... Biotech Ltd.,(NYSE Amex: SVA ), a leading developer and provider ... and six-,month periods ended June 30, 2009. , , ... to $20.0 million, -- Sales for the six-month period ... the quarter rose 52% to $10.7 million, -- Operating ...
... responsible for more than two thirds of the total ... newly adapted low-dose technique called adaptive statistical iterative reconstruction ... from CT up to 65 percent, according to a ... American Journal of Roentgenology (AJR). Iterative ...
Cached Medicine News:Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 2Health News:Are You Connected? AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 3Health News:User Centric to Present Health IT Usability Webinar Series 2Health News:Bayard Advertising Appointed by Hospital Corporation of America (HCA) West Florida Division for Recruitment Advertising and Employment Branding 2Health News:Health Experts Praise Intellicig Electronic Cigarette 2Health News:Health Experts Praise Intellicig Electronic Cigarette 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 13Health News:Sinovac Reports Unaudited Second Quarter 2009 Financial Results 14
(Date:11/22/2014)... 2014 Research and Markets  has announced the ... Report, 2014-2017" report to their offering. ... recombinant protein drug market has been expanding rapidly owing ... the like. During 2005-2013, sales of recombinant protein drugs ... of 19.1%, and it is projected that ...
(Date:11/21/2014)... SAN DIEGO , Nov. 21, 2014 /PRNewswire/ ... TNDM ), a medical device company and ... today announced a partnership with Tidepool, a non-profit ... an open source software platform that increases diabetes ... the Tidepool Platform, which is currently under development, ...
(Date:11/21/2014)... , Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... a stock purchase agreement to acquire 100% of QCR ... based distribution organization. The transaction closed on ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... Inc.,(NYSE:MDT) today announced that a review of ... that the trial has met its primary,non-inferiority ... a randomized, single-blind,trial evaluating the safety and ... as compared to the TAXUS Paclitaxel-Eluting,Coronary Stent ...
... Cardiovascular Target from Lexicon's Genetic,Research -, ... /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today reported ... directed to a,potential new target, angiopoietin-like ... cholesterol. Research suggests that,a monoclonal antibody ...
Cached Medicine Technology:ENDEAVOR IV Clinical Trial Meets Primary Endpoint 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 2Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 3Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 4Lexicon Develops Antibodies That Lower Triglycerides and,Cholesterol as Potential New Therapy for Heart Disease 5
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
... System facilitates the placement ... to cross and recanalize ... Safe-Cross system is a ... Coherence Reflectometry (OCR) Forward-looking ...
... patients and visitors is crucial for ... environment. Achieve this and more with ... patient and visitor identification system, fit ... can be used stand-alone, networked, or ...
Medicine Products: